Key facts
- This page summarizes NESTLE SA's Form 3 filing for Seres Therapeutics, Inc. (MCRB).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Oct 2024, 08:15.
NESTLE SA - 30 Sep 2024 Form 3 Insider Report for Seres Therapeutics, Inc. (MCRB)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MCRB
- Reported as of
- 30 Sep 2024
- Net transaction value
- $0
- Reporting owner signature
- SOCIETE DES PRODUITS NESTLE S.A., By: /s/ Claudio Kuoni, Name: Claudio Kuoni, Title: Vice President
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
NESTLE SA filed Form 3 for Seres Therapeutics, Inc. (MCRB) on 02 Oct 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MCRB
holding
Common Stock, par value $0.001
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 21,879,753
- Date
- 30 Sep 2024
- Ownership
- See Footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Held by Societe des Produits Nestle S.A. ("SPN"), a wholly-owned subsidiary of Nestle S.A. ("Nestle"). Nestle may be deemed to share voting and investment power with respect to the shares of Common Stock held by SPN.